Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults-Authors' reply

被引：1
|
作者：
Pertzov, B. [1 ,2 ]
Eliakim-Raz, N. [1 ,2 ]
Atamna, H. [1 ,2 ]
Trestioreanu, A. Z. [3 ]
Yahav, D. [2 ,4 ]
Leibovici, L. [1 ,2 ]
机构：
[1] Beilinson Med Ctr, Rabin Med Ctr, Dept Med E, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Beilinson Med Ctr, Rabin Med Ctr, Dept Family Med, Petah Tiqwa, Israel
[4] Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2019年 / 25卷 / 12期
关键词：
VENTILATOR-ASSOCIATED PNEUMONIA; MORTALITY; THERAPY;
D O I：
10.1016/j.cmi.2019.08.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1572 / 1573
页数：2
相关论文
共 50 条
  • [41] Dietary Coenzyme Q10 Suppressed Hepatic Hydroxymethylglutaryl-CoA Reductase Activity in Laying Hens
    Honda, Kazuhisa
    Saneyasu, Takaoki
    Motoki, Tohru
    Park, Yuriko
    Kamisoyama, Hiroshi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2013, 77 (07) : 1572 - 1574
  • [42] REGULATION OF HUMAN-LEUKOCYTE MICROSOMAL HYDROXYMETHYLGLUTARYL-COA REDUCTASE-ACTIVITY BY A PHOSPHORYLATION AND DEPHOSPHORYLATION MECHANISM
    HARWOOD, HJ
    SCHNEIDER, M
    STACPOOLE, PW
    BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 805 (03) : 245 - 251
  • [43] TISSUE SELECTIVITY OF HYDROXYMETHYLGLUTARYL COENZYME-A (HMG COA) REDUCTASE INHIBITORS
    SIRTORI, CR
    PHARMACOLOGY & THERAPEUTICS, 1993, 60 (03) : 431 - 459
  • [44] Serum Levels of Lipoprotein(a) and Homocysteine in Patients on Hemodialysis Who Take Hydroxymethylglutaryl-CoA Reductase Inhibitors, Vitamin B6, and Folic Acid
    Shojaei, Mir Hatef
    Djalali, Mamhmoud
    Siassi, Fereydoun
    Khatami, Mohammad Reza
    Boroumand, Mohammad Ali
    Eshragian, Mohammad Reza
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2009, 3 (03) : 141 - 144
  • [45] HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis
    Joel D. Mermis
    Steven Q. Simpson
    Current Infectious Disease Reports, 2012, 14 : 484 - 492
  • [46] EFFECT OF PUROMYCIN, CYCLOHEXIMIDE AND ACTINOMYCIN-D ON CIRCADIAN-RHYTHM OF HYDROXYMETHYLGLUTARYL-COA REDUCTASE IN MOUSE LIVER
    BERNDT, J
    LOWEL, M
    GAUMERT, R
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1972, 353 (09): : 1454 - &
  • [47] INHIBITION OF RAT-LIVER HYDROXYMETHYLGLUTARYL-COA REDUCTASE BY SULFHYDRYL-REAGENTS, COENZYME A ESTERS AND SYNTHETIC COMPOUNDS
    LIPPE, G
    DEANA, R
    CAVALLINI, L
    GALZIGNA, L
    BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) : 3293 - 3297
  • [48] HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis
    Mermis, Joel D.
    Simpson, Steven Q.
    CURRENT INFECTIOUS DISEASE REPORTS, 2012, 14 (05) : 484 - 492
  • [49] NEW SYNTHETIC INHIBITORS OF RAT-LIVER HYDROXYMETHYLGLUTARYL COA (HMG-COA) REDUCTASE
    DEANA, R
    LIPPE, G
    CAVALLINI, L
    QUADRO, G
    GALZIGNA, L
    JOURNAL OF LIPID RESEARCH, 1986, 27 (05) : 561 - 561
  • [50] HMG CoA reductase inhibitors (statins) for dialysis patients
    Palmer, Suetonia C.
    Navaneethan, Sankar D.
    Craig, Jonathan C.
    Johnson, David W.
    Perkovic, Vlado
    Nigwekar, Sagar U.
    Hegbrant, Jorgen
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
12345